GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Vishee Medical Technology Co Ltd (SHSE:688580) » Definitions » Stock Based Compensation

Nanjing Vishee Medical Technology Co (SHSE:688580) Stock Based Compensation : ¥0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nanjing Vishee Medical Technology Co Stock Based Compensation?

Nanjing Vishee Medical Technology Co's Stock Based Compensation for the three months ended in Mar. 2024 was ¥0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.0 Mil.


Nanjing Vishee Medical Technology Co Stock Based Compensation Historical Data

The historical data trend for Nanjing Vishee Medical Technology Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Vishee Medical Technology Co Stock Based Compensation Chart

Nanjing Vishee Medical Technology Co Annual Data
Trend Dec13 Dec14 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nanjing Vishee Medical Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nanjing Vishee Medical Technology Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.


Nanjing Vishee Medical Technology Co Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Nanjing Vishee Medical Technology Co's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Vishee Medical Technology Co (SHSE:688580) Business Description

Traded in Other Exchanges
N/A
Address
No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012
Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.
Executives
Huang He Senior management, core technical personnel
Chou Kai Senior management, core technical personnel
Zhong Yi Qun senior management
Chen Li Li Directors, senior managers
Zhang Hui senior management
Gao Fei Core technical personnel
Lian Qing Ming Director

Nanjing Vishee Medical Technology Co (SHSE:688580) Headlines

No Headlines